Dixie Group Q3 net loss narrows to $0.15/share; gross margin improves to 26.6%

DIXIE GROUP INC

2023-Q3 EPS reported -$0.40 revenue$209,669,000

Net loss from continuing operations $2.211M ($0.15 per share) vs $8.372M ($0.55) in Q3 2022.
Net sales $68.576M (-4.4% YoY); gross margin rose to 26.6% from 17.5% a year ago.
Nine-month net loss $5.382M ($0.36) improved from $15.734M ($1.04) in prior-year period.
Debt reduced ~$3M from prior year-end; availability under line of credit $15.9M.
Order entry in first five weeks of Q4 up slightly YoY; company to start nylon extrusion in Q1 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

DIXIE GROUP INC reported third quarter ended September 30, 2023 results: revenue net sales of $68,576,000, net income net loss from continuing operations ... was $2,211,000, EPS $0.15 per diluted share.

Period: third quarter ended September 30, 2023
Revenue: net sales of $68,576,000
Net income: net loss from continuing operations ... was $2,211,000
EPS: $0.15 per diluted share
Result: reported results

Exact text from the filing

For the third quarter of 2023, the Company had net sales of $68,576,000 as compared to $71,762,000 in the same quarter of 2022. The operating loss on the quarter was $913,000 compared to a loss of $7,150,000 in the same period of the prior year. The net loss from continuing operations for the three months of the third quarter of 2023 was $2,211,000 or $0.15 per diluted share. In 2022, the net loss from continuing operations for the third quarter was $8,372,000 or $0.55 per diluted share.

View on SEC.gov

Browse all earnings releases →

DIXIE GROUP INC filing history →

Source: SEC EDGAR

accession 0000029332-23-000090

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.